EKSO
EKSO
NASDAQ · Health Care

Ekso Bionics Holdings Inc

$14.28
-0.15 (-1.01%)
As of May 16, 2:23 AM ET ·
Financial Highlights (FY 2026)
Revenue
15.53M
Net Income
-14,194,698
Gross Margin
53.5%
Profit Margin
-91.4%
Rev Growth
-0.3%
D/E Ratio
0.45
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 53.5% 53.5% 46.6% 46.6%
Operating Margin -104.1% -93.7% 13.8% 15.5%
Profit Margin -91.4% -86.8% 12.1% 12.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 15.53M 15.58M 13.83M 15.57M
Gross Profit 8.31M 8.33M 6.44M 7.25M
Operating Income -16,174,785 -14,599,645 1.91M 2.42M
Net Income -14,194,698 -12,812,384 1.67M 1.88M
Gross Margin 53.5% 53.5% 46.6% 46.6%
Operating Margin -104.1% -93.7% 13.8% 15.5%
Profit Margin -91.4% -86.8% 12.1% 12.1%
Rev Growth -0.3% -0.3% +15.1% +20.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 6.52M 6.52M 5.34M 6.07M
Total Equity 14.51M 14.51M 22.03M 21.18M
D/E Ratio 0.45 0.45 0.24 0.29
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -14,295,401 -13,620,129 2.69M 3.16M
Free Cash Flow 1.57M 1.27M